Seroquel
NDC Package 64725-0281-1

11-digit billing NDC: 64725028101

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Seroquel is hypersensitivity to quetiapine or to any excipients in the SEROQUEL XR formulation. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-0281 and is authorized under FDA application NDA022047.

Identification & Billing

NDC Package Code
64725-0281-1
Package Description
60 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
64725028101
RxNorm Crosswalk
  • RxCUI: 721791 - QUEtiapine fumarate 200 MG 24HR Extended Release Oral Tablet
  • RxCUI: 721791 - 24 HR quetiapine 200 MG Extended Release Oral Tablet
  • RxCUI: 721791 - quetiapine 200 MG (as quetiapine fumarate 230 MG) 24 HR Extended Release Oral Tablet
  • RxCUI: 721791 - quetiapine 200 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 721793 - SEROQUEL XR 200 MG 24HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Seroquel XR
Dosage Form
-
Usage Information
Hypersensitivity to quetiapine or to any excipients in the SEROQUEL XR formulation. Anaphylactic reactions have been reported in patients treated with SEROQUEL XR.

Regulatory & Marketing

Labeler Name
Tya Pharmaceuticals
FDA Application #
NDA022047
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-01-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64725-0281-1 identifies a specific commercial package of 60 tablet, extended release in 1 bottle of Seroquel XR, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on February 01, 2009. The current certification is valid through December 31, 2017.

How is this Tya Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725028101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
64725-0281-1
11-Digit CMS (5-4-2)
64725-0281-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.